eGenesis
Xenotransplantation
3 open roles Xenotransplantation Cambridge, United States 144 employees $481M raised Est. 2015
Lux Capital
Khosla Ventures
ARCH Venture Partners
Farallon Capital Management
DaVita
Eisai Innovation
About eGenesis
eGenesis is a biotechnology company developing human-compatible engineered organs and cells to address the global shortage of transplantable organs.
eGenesis is listed on Rocketlist with 3 active roles. The company is categorized as Xenotransplantation in BioTech. eGenesis is at Series D stage, with a B2B business model, headquartered in Cambridge, United States. eGenesis was founded in 2015 and has 144 employees. eGenesis has raised $481M. Active roles are refreshed daily from public hiring sources.